PRME
Prime Medicine
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
PRME Profile
Prime Medicine, Inc.
A biotechnology company that focused on cure genetic disorders by deploying Prime Editing technology
Biological Technology
Invalid Date
10/20/2022
NASDAQ Stock Exchange
214
12-31
Common stock
60 First Street, Cambridge, MA 02141
--
Prime Medicine, Inc., was incorporated in Delaware in September 2019. The company is a biotechnology company dedicated to delivering a new class of differentiated one-time therapeutic gene therapies — Prime Editors, which address the broadest spectrum of diseases by deploying Prime Editing technology.